Related Experiment Videos

Beyond screening: challenges in measuring outcomes

Perla D Santos Ocampo1, Rita Paz Rowena De Guzman, Barbra Charina Cavan

  • 1Department of Pediatrics, College of Medicine, Philippine General Hospital, Manila.

The Southeast Asian Journal of Tropical Medicine and Public Health
|May 24, 2005
PubMed

Insights

Newborn screening is vital for early identification and intervention, improving developmental outcomes for children. Sustained compliance and periodic monitoring are key to successful long-term follow-up care.

Area of Science:

  • Pediatrics
  • Developmental Biology
  • Public Health

Background:

  • Newborn screening programs identify infants with serious genetic, metabolic, and endocrine disorders.
  • Post-identification outcomes, particularly developmental aspects, are crucial for pediatricians.
  • The Philippine Newborn Screening Program is relatively new but offers valuable experiences.

Purpose of the Study:

  • To outline key messages for pediatricians regarding patient outcomes after newborn screening.
  • To emphasize the importance of developmental aspects in long-term patient follow-up.
  • To discuss strategies for improving follow-up care in a developing country context.

Main Methods:

  • Review of essential assumptions for improving developmental outcomes post-newborn screening.
  • Identification of critical features for quality follow-up care.
  • Consideration of challenges and strategies within a developing country setting.

Main Results:

  • Newborn screening enables early case identification, which generally enhances developmental outcome.
  • Sustained compliance, increased awareness of influencing factors, and periodic developmental monitoring are essential for better outcomes.
  • Strategies exist to overcome challenges in developing countries, aiming for available, accessible, affordable, accurate, and adequate follow-up.

Conclusions:

  • Early identification and intervention through newborn screening significantly impact developmental outcomes.
  • A multi-faceted approach including sustained compliance and regular monitoring is necessary for optimal patient development.
  • Improving follow-up care in developing nations requires addressing availability, accessibility, affordability, accuracy, and adequacy.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Nursing Evaluation01:15

Nursing Evaluation

The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
Section...